Literature DB >> 11335966

Ascitic fluid cytology of adenosarcoma of the ovary: a case report.

E Hirakawa1, S Kobayashi, H Miki, R Haba, K Saoo, K Yamakawa, I Ohkura, Y Kira.   

Abstract

Extrauterine adenosarcoma is very rare and originates in the ovary, adnexa, or myometrium. Cytologic study of ascites is very important to determine clinical staging of malignant ovarian tumors and provide adequate therapy for recurrence. The cytomorphologic features of adenosarcoma have been only rarely described. A 77-yr-old woman visited a hospital with a complaint of lower abdominal pain for 1 mo. A tumor originating from the right adnexa in the pelvis, and involving the rectum, was found in surgery. In the ascitic fluid cytology, a few dispersed tumor cells with large cytoplasm and nuclei were oval-shaped, with nuclear invagination. The chromatin was finely granular; one or two nucleoli were conspicuous. To our knowledge, this is the fifteenth reported case of adenosarcoma of the ovary, and there have been no prior reports describing the cytological features of ascitic fluid cells in adenosarcoma of the ovary. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11335966     DOI: 10.1002/dc.1074

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

Review 1.  Uterine Adenosarcoma: a Review.

Authors:  Michael J Nathenson; Vinod Ravi; Nicole Fleming; Wei-Lien Wang; Anthony Conley
Journal:  Curr Oncol Rep       Date:  2016-11       Impact factor: 5.075

2.  Primary ovarian adenosarcoma with elevated Ca-125 levels and normal ascitic fluid cytology: a case report and review of literature.

Authors:  Pn Shakuntala; K Umadevi; A Usha; N Abhilasha; Ud Bafna
Journal:  Ecancermedicalscience       Date:  2012-12-17

3.  Advanced Mesodermal (Müllerian) Adenosarcoma of the Ovary: Metastases to the Lungs, Mouth, and Brain.

Authors:  A Daskalaki; S Xenaki; E Athanasakis; E Chrysos; G Chalkiadakis
Journal:  Case Rep Surg       Date:  2015-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.